RNU2-69P

Across TCGA pan-cancer cohorts, RNU2-69P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RNU2-69P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU2-69P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU2-69P expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.

LIHC, READ, and KIRP are the cancer types where RNU2-69P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.219	0.573	<.001	84	view →
READ	OS	Tertile	III,IV	0.386	0.767	.003	57	view →
KIRP	DFS	Tertile	II,III,IV	0.520	0.765	.002	51	view →
LAML	DFS	Tertile	All	0.312	0.575	.001	40	view →
UVM	DFS	Tertile	All	0.330	0.634	.041	36	view →
LGG	OS	Median	All	0.738	0.902	<.001	30	view →
BLCA	DFS	Tertile	II,III,IV	0.507	0.652	.008	27	view →
THCA	OS	Quartile	III,IV	0.311	0.973	.005	27	view →
MESO	DFS	Tertile	All	0.169	0.532	.024	27	view →
ACC	DFS	Tertile	III,IV	0.082	0.483	.014	21	view →
SARC	DFS	Tertile	All	0.435	0.633	.012	9	view →
PCPG	DFS	Tertile	All	0.642	0.874	.027	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RNU2-69P–LIHC (DFS)

Open the LIHC breakdown →